Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.37
-0.09 (-1.74%)
At close: Aug 13, 2025, 4:00 PM
5.37
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $130.00K in the quarter ending June 30, 2025, with 154.90% growth. This brings the company's revenue in the last twelve months to $130.00K, down -95.90% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.
Revenue (ttm)
$130.00K
Revenue Growth
-95.90%
P/S Ratio
430.52
Revenue / Employee
$10,000
Employees
13
Market Cap
54.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
Dec 31, 2023 | 3.15M | 2.56M | 433.05% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 2 days ago - Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 15 days ago - Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) - GlobeNewsWire
- 16 days ago - Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Makes Grant to New Employee Under Inducement Plan - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025 - GlobeNewsWire
- 2 months ago - UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 - GlobeNewsWire
- 2 months ago - Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 - GlobeNewsWire